Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.25 AUD | +0.55% | +14.85% | +81.05% |
Business Summary
Number of employees: 234
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Commercial
98.9
%
| 156 | 97.7 % | 497 | 98.9 % | +217.87% |
Product Development
1.1
%
| 4 | 2.3 % | 5 | 1.1 % | +47.46% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
97.4
%
| 150 | 93.7 % | 490 | 97.4 % | +226.42% |
China
1.1
%
| 3 | 2.1 % | 5 | 1.1 % | +57.80% |
Other Countries
0.9
%
| 2 | 1.6 % | 5 | 0.9 % | +87.06% |
United Kingdom
0.3
%
| 2 | 1.3 % | 1 | 0.3 % | -36.14% |
Australia
0.2
%
| 0 | 0.1 % | 1 | 0.2 % | +682.55% |
Belgium
0.1
%
| 1 | 0.4 % | 0 | 0.1 % | -18.79% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andreas Kluge
FOU | Founder | - | 15-10-31 |
Founder | 49 | 15-10-31 | |
Darren Smith
DFI | Director of Finance/CFO | 58 | 22-01-31 |
Craig Ulrick
CTO | Chief Tech/Sci/R&D Officer | - | - |
Tracey Brown
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-01-31 |
Chief Tech/Sci/R&D Officer | - | - | |
Melanie Farris
CMP | Compliance Officer | - | - |
David Cade
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-10-06 |
Kyahn Williamson
IRC | Investor Relations Contact | - | 21-07-11 |
Meredith Crowe
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Harry McCann
CHM | Chairman | 83 | 17-09-16 |
Founder | 49 | 15-10-31 | |
Mark Nelson
BRD | Director/Board Member | 64 | 17-09-16 |
Tiffany Olson
BRD | Director/Board Member | 64 | 22-03-30 |
Jann Skinner
BRD | Director/Board Member | 66 | 18-06-18 |
Andreas Kluge
FOU | Founder | - | 15-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 323,727,000 | 195,455,627 ( 60.38 %) | 0 | 60.38 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
3,298,073 | 1.00% | 32,231,144 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+81.05% | 4.07B | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- TLX Stock
- Company Telix Pharmaceuticals Limited